The MYD88 p.(Leu265Pro) mutation has been indicated to be the hallmark change in patients with Waldenstrom macroglobulinemia (WM). This mutation is also reported in patients with splenic marginal zone lymphoma (SMZL) and in other B-cell chronic lymphoproliferative disorders.
Amplification specific Polymerase Chain Reaction (AS-
Test |
Cost NZD* |
Sample Requirements |
Current TAT |
---|---|---|---|
MYD88 p.(Leu265Pro) Mutation testing |
$213 | 1 ml of bone marrow or 2x4ml of whole blood (if malignant cells are circulating in peripheral blood) in EDTA |
1 week For urgent cases please contact the laboratory
|